RAPT Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	37.93	169.74	47.48	38.95	24.03	24.92
Short-Term Investments	119.41	61.32	111.38	210.12	165.63	86.59
Cash & Short-Term Investments	157.34	231.06	158.86	249.07	189.65	111.51
Cash Growth	60.71%	45.44%	-36.22%	31.33%	70.08%	44.10%
Other Current Assets	3.7	4.18	2.92	3.63	3.32	4.09
Total Current Assets	161.05	235.24	161.78	252.69	192.97	115.6
Net Property, Plant & Equipment	2.65	4.7	7.68	9.48	2.74	2.98
Other Long-Term Assets	2.05	0.39	3.87	4.04	2.92	0.39
Total Assets	165.74	240.33	173.33	266.21	198.64	118.97
Accounts Payable	2.1	1.28	5.18	3.37	2	2.38
Accrued Expenses	9.01	9.6	14.1	8.66	6.33	4.94
Current Portion of Leases	2.21	2.42	2.45	2.17	-	-
Unearned Revenue	-	-	-	-	1.02	4.1
Other Current Liabilities	0.06	35.06	0.11	0.03	0.25	0.33
Total Current Liabilities	13.38	48.35	21.84	14.22	9.6	11.74
Long-Term Leases	0.39	2.07	4.46	6.82	-	-
Other Long-Term Liabilities	-	-	-	-	2.66	3.05
Total Long-Term Liabilities	0.39	2.07	4.46	6.82	2.66	3.05
Total Liabilities	13.76	50.42	26.29	21.04	12.26	14.79
Common Stock	0	0.01	0	0	0	0
Additional Paid-in Capital	818.81	804.39	631.61	613.07	470.63	319.2
Accumulated Other Comprehensive Income	0.1	0.05	0.1	-0.03	-0.21	-0.18
Retained Earnings	-666.94	-614.55	-484.68	-367.88	-284.05	-214.84
Shareholders' Equity	151.98	189.9	147.04	245.17	186.38	104.18
Total Liabilities & Equity	165.74	240.33	173.33	266.21	198.64	118.97
Total Debt	2.6	4.49	6.91	8.99	0	0
Net Cash (Debt)	154.75	226.56	151.96	240.08	189.65	111.51
Net Cash Growth	-31.70%	49.10%	-36.71%	26.59%	70.08%	44.10%
Net Cash Per Share	7.14	44.47	31.71	59.02	55.39	36.96
Book Value	151.98	189.9	147.04	245.17	186.38	104.18
Book Value Per Share	7.01	37.27	30.68	60.27	54.44	34.53
Tangible Book Value	151.98	189.9	147.04	245.17	186.38	104.18
Tangible Book Value Per Share	7.01	37.27	30.68	60.27	54.44	34.53

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q